Jiangsu TaslyDiYi Pharmaceutical Co., Ltd
As of 20 November 2026, for the company name Jiangsu TaslyDiYi Pharmaceutical Co., Ltd as recorded, 12 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 41 records, across 28 drug names; since 24 August 2026, the records list No longer listed under review: 1 application; the chemical-drug catalogue lists 28 active records with this name as holder; 31 active API registrations list this name as first registered company; 4 further acceptance records name it after the first applicant.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/20.
Drug filings
41 acceptance records as first applicant, grouped into 28 source drug names. Source data as of 2026/11/20.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Sevelamer Carbonate Tablets 2 records · Latest accepted 2026/07/06
Generic · 2
Propranolol hydrochloride oral solution 1 records · Latest accepted 2026/06/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601449 | Generic | 2026/06/18 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
Ambroxol Hydrochloride Drops 1 records · Latest accepted 2026/06/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601448 | Generic | 2026/06/18 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
Teneligliptin Hydrobromide Hydrate Tablets 1 records · Latest accepted 2025/12/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504230 | Generic | 2025/12/10 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
JS1-1-01片 · No verified English name 1 records · Latest accepted 2025/12/03
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2500320 | Supplement | 2025/12/03 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ) 1 records · Latest accepted 2025/09/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503405 | Generic | 2025/09/16 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
达格列净二甲双胍缓释片(II) · No verified English name 1 records · Latest accepted 2025/09/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503406 | Generic | 2025/09/16 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets(III) 1 records · Latest accepted 2025/09/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503407 | Generic | 2025/09/16 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
Azilsartan Medoxomil Potassium Tablets 2 records · Latest accepted 2025/08/08
Generic · 2
TSL2109胶囊 · No verified English name 2 records · Latest accepted 2025/07/24
New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2500754 | New drug | 2025/07/24 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd; Zhongguo Yao Ke University romanized | CDE ↗ |
| CXHL2500753 | New drug | 2025/07/24 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd; Zhongguo Yao Ke University romanized | CDE ↗ |
盐酸西替利嗪滴剂 · No verified English name 1 records · Latest accepted 2025/06/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502279 | Generic | 2025/06/26 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
地氯雷他定口服溶液 · No verified English name 2 records · Latest accepted 2025/05/22
Generic · 2
PXT3003 · No verified English name 1 records · Latest accepted 2025/04/11
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2500027 | New drug | 2025/04/11 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
Raltitrexed for Injection 1 records · Latest accepted 2025/01/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500130 | Generic | 2025/01/08 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
波生坦分散片 · No verified English name 1 records · Latest accepted 2024/12/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404493 | Generic | 2024/12/24 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
Vonoprazan Fumarate Tablets 2 records · Latest accepted 2024/09/30
Generic · 2
Minoxidil Liniment 2 records · Latest accepted 2024/04/26
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401276 | Generic | 2024/04/26 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd; Henan Tian Di Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2401275 | Generic | 2024/04/26 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd; Henan Tian Di Pharma Co., Ltd. romanized | CDE ↗ |
Torsemide Injection 2 records · Latest accepted 2023/10/24
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302873 | Generic | 2023/10/24 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd; Chengdu Shi Hai Tong Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2302872 | Generic | 2023/10/24 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd; Chengdu Shi Hai Tong Pharma Co., Ltd. romanized | CDE ↗ |
Rivaroxaban Tablets 4 records · Latest accepted 2023/10/11
Supplement · 1Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2302243 | Supplement | 2023/10/11 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
| CYHS2200137 | Generic | 2022/01/20 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
| CYHS2200136 | Generic | 2022/01/20 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
| CYHS2200135 | Generic | 2022/01/20 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
Ketotifen Fumarate Tablets 1 records · Latest accepted 2023/07/12
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350557 | Supplement | 2023/07/12 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
Nicorandil Tablets 1 records · Latest accepted 2023/06/12
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350487 | Supplement | 2023/06/12 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
Dapoxetine Hydrochloride Tablets 2 records · Latest accepted 2023/05/16
Generic · 2
Baclofen Oral Solution 1 records · Latest accepted 2023/04/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301070 | Generic | 2023/04/18 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd; Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Perampanel Tablets 2 records · Latest accepted 2022/08/31
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201422 | Generic | 2022/08/31 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd; Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2201421 | Generic | 2022/08/31 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd; Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Procaterol Hydrochloride Oral Solution 1 records · Latest accepted 2022/07/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201079 | Generic | 2022/07/15 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd; Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Lisinopril and Hydrochlorothiazide Tablets 1 records · Latest accepted 2021/08/05
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150780 | Supplement | 2021/08/05 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
Tadalafil Tablets 2 records · Latest accepted 2021/03/25
Supplement · 2
Bortezomib For Injection 1 records · Latest accepted 2021/02/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2100144 | Generic | 2021/02/02 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
Changes in the last 90 days
1 events from 2026/08/24 to 2026/11/21. CDE data as of 2026/11/20; NMPA data as of 2026/11/20.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
No longer listed under review: 1 application
- 2026/11/20No longer listed under review
PXT3003 · No verified English name
CXHS2500027
Fact date: 2026/11/20 · Date added to this site: 2026/11/20
Accepted: 2025/04/11
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗
Under review
12 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/20.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Sevelamer Carbonate Tablets | CYHS2601599 | Generic | 2026/07/06 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
| Propranolol hydrochloride oral solution | CYHS2601449 | Generic | 2026/06/18 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
| Ambroxol Hydrochloride Drops | CYHS2601448 | Generic | 2026/06/18 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
| Teneligliptin Hydrobromide Hydrate Tablets | CYHS2504230 | Generic | 2025/12/10 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
| Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets(III) | CYHS2503407 | Generic | 2025/09/16 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
| 达格列净二甲双胍缓释片(II) · No verified English name | CYHS2503406 | Generic | 2025/09/16 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
| Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ) | CYHS2503405 | Generic | 2025/09/16 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
| Azilsartan Medoxomil Potassium Tablets | CYHS2502864 | Generic | 2025/08/08 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
| Azilsartan Medoxomil Potassium Tablets | CYHS2502863 | Generic | 2025/08/08 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
| 盐酸西替利嗪滴剂 · No verified English name | CYHS2502279 | Generic | 2025/06/26 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
| 地氯雷他定口服溶液 · No verified English name | CYHS2501850 | Generic | 2025/05/22 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
| 地氯雷他定口服溶液 · No verified English name | CYHS2501849 | Generic | 2025/05/22 | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
Catalogue holder records
28 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/20. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | NMPA approval no. | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 波生坦分散片 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H20264688 | 2026/06/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vonoprazan Fumarate Tablets | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H20264408 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vonoprazan Fumarate Tablets | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H20264409 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Torsemide Injection | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Chengdu Shi Hai Tong Pharma Co., Ltd. romanized | 国药准字H20254226 | 2025/05/20 | Not stated by source | CDE ↗ |
| Torsemide Injection | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Chengdu Shi Hai Tong Pharma Co., Ltd. romanized | 国药准字H20254225 | 2025/05/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rivaroxaban Tablets | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H20247183 | 2024/08/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapoxetine Hydrochloride Tablets | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H20244358 | 2024/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapoxetine Hydrochloride Tablets | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H20244359 | 2024/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ketotifen Fumarate Tablets | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H32023660 | 2024/06/14 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Nicorandil Tablets | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H32025656 | 2024/03/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Rivaroxaban Tablets | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H20233999 | 2023/08/01 | Not stated by source | CDE ↗ |
| Rivaroxaban Tablets | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H20234000 | 2023/08/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bortezomib For Injection | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H20223631 | 2022/08/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lisinopril and Hydrochlorothiazide Tablets | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H20080080 | 2022/08/23 | Not stated by source | CDE ↗ |
| Memantine Hydrochloride Sustained-release Capsules | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H20213939 | 2021/12/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Memantine Hydrochloride Sustained-release Capsules | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H20213938 | 2021/12/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tadalafil Tablets | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H20217123 | 2021/11/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Temozolomide For Injection | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H20213793 | 2021/10/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bezafibrate Sustained Realease Tablets | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H20213796 | 2021/10/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tadalafil Tablets | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H20217085 | 2021/10/10 | Other drug | CDE ↗ |
| Clozapine Tablets | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H32023125 | 2021/01/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Metformin Hydrochloride Tablets | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H32020197 | 2021/01/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Minodronic acid Tablets | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H20203736 | 2020/12/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 吉非替尼片 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H20203704 | 2020/12/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Captopril Tablets | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H32023124 | 2020/10/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Sulpiride Tablets | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H32023126 | 2020/07/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Trihexyphenidyl Hydrochloride Tablets | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H32023129 | 2020/04/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tadalafil Tablets | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | 国药准字H20193416 | 2019/12/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
31 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/20.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 乌帕替尼 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20250001484 | I | 2026/02/14 | CDE ↗ |
| 利非司特 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20250001421 | I | 2025/12/23 | CDE ↗ |
| 氢溴酸替格列汀 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20250001275 | I | 2025/11/28 | CDE ↗ |
| 佐匹克隆 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20250000459 | A | 2026/10/16 | CDE ↗ |
| 酒石酸匹莫范色林 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20250000066 | I | 2025/02/07 | CDE ↗ |
| 枸橼酸伊沙佐米 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20250000103 | A | 2026/06/30 | CDE ↗ |
| 雷替曲塞 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20240001432 | A | 2026/08/04 | CDE ↗ |
| 波生坦 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20240001390 | A | 2026/05/21 | CDE ↗ |
| 富马酸伏诺拉生 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20240000817 | A | 2026/03/26 | CDE ↗ |
| 右佐匹克隆 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20230001009 | A | 2025/05/23 | CDE ↗ |
| 盐酸苯达莫司汀 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20230000544 | A | 2024/12/13 | CDE ↗ |
| 马来酸阿法替尼 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20210000923 | A | 2023/08/21 | CDE ↗ |
| 利伐沙班 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20210001082 | A | 2023/04/07 | CDE ↗ |
| 硼替佐米 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20200001372 | A | 2022/08/18 | CDE ↗ |
| 左舒必利 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20190021489 | I | 2020/01/10 | CDE ↗ |
| 他达拉非 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20190021561 | A | 2024/11/12 | CDE ↗ |
| 阿德福韦酯 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20190008281 | A | — | CDE ↗ |
| 盐酸非索非那定 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20190006077 | A | 2025/08/22 | CDE ↗ |
| 盐酸吡格列酮 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20190005807 | A | 2025/06/21 | CDE ↗ |
| 苯扎贝特 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20190003930 | A | 2025/06/05 | CDE ↗ |
| 西洛他唑 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20190003352 | A | 2025/05/29 | CDE ↗ |
| 舒必利 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20190003338 | A | 2025/05/31 | CDE ↗ |
| 尼可地尔 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20190003337 | A | 2025/06/21 | CDE ↗ |
| 盐酸硫必利 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20190003336 | A | 2025/06/13 | CDE ↗ |
| 葡醛内酯 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20190003334 | A | — | CDE ↗ |
| 水飞蓟宾 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20190003331 | A | 2025/06/21 | CDE ↗ |
| 氟他胺 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20190003329 | A | 2025/05/29 | CDE ↗ |
| 替莫唑胺 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20190003328 | A | 2025/06/13 | CDE ↗ |
| 替米沙坦 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20190003325 | A | 2025/05/29 | CDE ↗ |
| 卡培他滨 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20170000321 | A | 2025/06/05 | CDE ↗ |
| 盐酸苯海索 · No verified English name | Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | Y20170000242 | A | 2023/04/05 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
4 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/20.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Bendamustine Hydrochloride For Injection | CYHS2302078 | Generic | 2023/08/02 | Nanjing Li Cheng Pharma Co., Ltd. romanized; Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
| Bendamustine Hydrochloride For Injection | CYHS2302077 | Generic | 2023/08/02 | Nanjing Li Cheng Pharma Co., Ltd. romanized; Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
| Afatinib Dimaleate Tablets | CYHS2200082 | Generic | 2022/01/13 | Jiangsu Kang Bei De Pharma Co., Ltd. romanized; Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
| Afatinib Dimaleate Tablets | CYHS2200081 | Generic | 2022/01/13 | Jiangsu Kang Bei De Pharma Co., Ltd. romanized; Jiangsu TaslyDiYi Pharmaceutical Co., Ltd | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/20
- Chemical-drug catalogue
- Last successful update: 2026/11/20
- API registrations
- Last successful update: 2026/11/20
- NMPA drug delivery notices
- Last successful update: 2026/11/20
Loaded notices dated 2026-11-06 to 2026-11-20; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.